REYATAZ is a Oral Capsule, Gelatin Coated in the Human Prescription Drug category. It is labeled and distributed by E.r. Squibb & Sons, L.l.c.. The primary component is Atazanavir Sulfate.
Product ID | 0003-3624_1cab2232-648a-4961-a179-30087315de3b |
NDC | 0003-3624 |
Product Type | Human Prescription Drug |
Proprietary Name | REYATAZ |
Generic Name | Atazanavir |
Dosage Form | Capsule, Gelatin Coated |
Route of Administration | ORAL |
Marketing Start Date | 2003-06-24 |
Marketing End Date | 2023-04-30 |
Marketing Category | NDA / NDA |
Application Number | NDA021567 |
Labeler Name | E.R. Squibb & Sons, L.L.C. |
Substance Name | ATAZANAVIR SULFATE |
Active Ingredient Strength | 150 mg/1 |
Pharm Classes | Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA] |
NDC Exclude Flag | N |
Marketing Start Date | 2003-06-24 |
Marketing End Date | 2023-04-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021567 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2003-06-24 |
Ingredient | Strength |
---|---|
ATAZANAVIR SULFATE | 150 mg/1 |
SPL SET ID: | 165cff62-b284-4a27-a65d-9ec8a5bfcdd8 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0003-3622 | REYATAZ | ATAZANAVIR |
0003-3624 | REYATAZ | ATAZANAVIR |
0003-3631 | REYATAZ | ATAZANAVIR |
0003-3638 | REYATAZ | ATAZANAVIR |
50090-1007 | REYATAZ | ATAZANAVIR |
50090-1581 | REYATAZ | ATAZANAVIR |
69189-3631 | REYATAZ | REYATAZ |
69189-3624 | REYATAZ | REYATAZ |
70518-0725 | REYATAZ | REYATAZ |
70518-0688 | REYATAZ | REYATAZ |
70518-0469 | REYATAZ | REYATAZ |
67296-1236 | REYATAZ | REYATAZ |
31722-653 | Atazanavir | Atazanavir |
31722-654 | Atazanavir | Atazanavir |
31722-655 | Atazanavir | Atazanavir |
42385-920 | Atazanavir | Atazanavir |
42385-921 | Atazanavir | Atazanavir |
42385-922 | Atazanavir | Atazanavir |
59762-0408 | ATAZANAVIR | ATAZANAVIR |
59762-0409 | ATAZANAVIR | ATAZANAVIR |
59762-0410 | ATAZANAVIR | ATAZANAVIR |
0904-6875 | Atazanavir Sulfate | Atazanavir |
16714-860 | Atazanavir Sulfate | Atazanavir |
16714-861 | Atazanavir Sulfate | Atazanavir |
16714-862 | Atazanavir Sulfate | Atazanavir |
60687-399 | Atazanavir Sulfate | Atazanavir |
65862-710 | Atazanavir Sulfate | Atazanavir |
65862-711 | Atazanavir Sulfate | Atazanavir |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
REYATAZ 78804555 not registered Dead/Abandoned |
Bristol-Myers Squibb Company 2006-02-01 |
REYATAZ 78169764 not registered Dead/Abandoned |
Bristol-Myers Squibb Company 2002-10-01 |
REYATAZ 78169761 not registered Dead/Abandoned |
Bristol-Myers Squibb Company 2002-10-01 |
REYATAZ 78169757 not registered Dead/Abandoned |
Bristol-Myers Squibb Company 2002-10-01 |
REYATAZ 78169754 not registered Dead/Abandoned |
Bristol-Myers Squibb Company 2002-10-01 |
REYATAZ 78131406 2846482 Live/Registered |
Bristol-Myers Squibb Company 2002-05-28 |
REYATAZ 77829869 4415058 Live/Registered |
Bristol-Myers Squibb Company 2009-09-18 |